Actio Biosciences
United States · $121.0M raised
- Business Model
- B2B
- Website
- actiobiosciences.com
- Total Funding
- $121.0M
- Last Round
- $66.0M Series BJun 2025
- Rounds
- 2
About
Clinical-stage biotech leveraging genetics and precision medicine to develop therapeutics targeting shared biology in rare and common diseases.
Summary
Actio Biosciences is a Biotech company based in United States. It has raised $121.0M in total across 2 rounds, most recently a $66.0M Series B round in Jun 2025. Investors include Deerfield Management, Regeneron Ventures and Canaan Partners.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jun 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...